» Articles » PMID: 32057769

The Spike Glycoprotein of the New Coronavirus 2019-nCoV Contains a Furin-like Cleavage Site Absent in CoV of the Same Clade

Overview
Journal Antiviral Res
Publisher Elsevier
Date 2020 Feb 15
PMID 32057769
Citations 951
Authors
Affiliations
Soon will be listed here.
Abstract

In 2019, a new coronavirus (2019-nCoV) infecting Humans has emerged in Wuhan, China. Its genome has been sequenced and the genomic information promptly released. Despite a high similarity with the genome sequence of SARS-CoV and SARS-like CoVs, we identified a peculiar furin-like cleavage site in the Spike protein of the 2019-nCoV, lacking in the other SARS-like CoVs. In this article, we discuss the possible functional consequences of this cleavage site in the viral cycle, pathogenicity and its potential implication in the development of antivirals.

Citing Articles

Identification of Furin Protease Small-Molecule Inhibitor with a 1,3-Thiazol-2-ylaminosulfonyl Scaffold.

Kolaric A, Ravnik V, Stumpf Horvat S, Jukic M, Bren U Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006084 PMC: 11859198. DOI: 10.3390/ph18020273.


Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions.

Pencheva M, Manchorova-Veleva N, Baruh D, Rusinov G, Vangelov L Life (Basel). 2025; 15(2).

PMID: 40003732 PMC: 11857456. DOI: 10.3390/life15020324.


Micro-Epigenetic Markers in Viral Genome: SARS-CoV-2 Infection Impact on Host Cell MicroRNA Landscape.

Chrysovergis A, Papanikolaou V, Roukas D, Spyropoulou D, Mastronikoli S, Papouliakos S Maedica (Bucur). 2025; 19(4):842-847.

PMID: 39974441 PMC: 11834827. DOI: 10.26574/maedica.2024.19.4.842.


Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes.

Neerukonda S, Vassell R, Lusvarghi S, Liu S, Akue A, Kukuruga M Microbiol Spectr. 2025; 13(3):e0280824.

PMID: 39873512 PMC: 11878054. DOI: 10.1128/spectrum.02808-24.


Use of Tranexamic Acid in SARS-COV-2: Boon or Bane?.

Chandela M, Saxena A, Mehta R, Mohanty S, Singla P, Solanki A Arch Razi Inst. 2024; 79(3):459-464.

PMID: 39736938 PMC: 11682518. DOI: 10.32592/ARI.2024.79.3.459.


References
1.
Braun E, Sauter D . Furin-mediated protein processing in infectious diseases and cancer. Clin Transl Immunology. 2019; 8(8):e1073. PMC: 6682551. DOI: 10.1002/cti2.1073. View

2.
Mbikay M, Sirois F, Yao J, Seidah N, Chretien M . Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997; 75(10):1509-14. PMC: 2223512. DOI: 10.1038/bjc.1997.258. View

3.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

4.
Chan J, Kok K, Zhu Z, Chu H, To K, Yuan S . Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9(1):221-236. PMC: 7067204. DOI: 10.1080/22221751.2020.1719902. View

5.
Seidah N, Prat A . The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov. 2012; 11(5):367-83. DOI: 10.1038/nrd3699. View